N-(4-bromo-2-fluorophenyl)-2-[3-(4-fluorophenyl)-7-oxo-[1,2]thiazolo[4,5-d]pyrimidin-6-yl]acetamide
C19H11BrF2N4O2S — CID 50841770
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(4-bromo-2-fluorophenyl)-2-[3-(4-fluorophenyl)-7-oxo-[1,2]thiazolo[4,5-d]pyrimidin-6-yl]acetamide
N-(4-bromo-2-fluorophenyl)-2-[3-(4-fluorophenyl)-7-oxo-[1,2]thiazolo[4,5-d]pyrimidin-6-yl]acetamide (PubChem CID 50841770) has the molecular formula C19H11BrF2N4O2S and a molecular weight of 477.29 g/mol. Its IUPAC name is N-(4-bromo-2-fluorophenyl)-2-[3-(4-fluorophenyl)-7-oxo-[1,2]thiazolo[4,5-d]pyrimidin-6-yl]acetamide.
Molecular Properties
| Compound Name | N-(4-bromo-2-fluorophenyl)-2-[3-(4-fluorophenyl)-7-oxo-[1,2]thiazolo[4,5-d]pyrimidin-6-yl]acetamide |
|---|---|
| PubChem CID | 50841770 |
| Molecular Formula | C19H11BrF2N4O2S |
| Molecular Weight | 477.29 g/mol |
| Exact Mass | 475.98 |
| IUPAC Name | N-(4-bromo-2-fluorophenyl)-2-[3-(4-fluorophenyl)-7-oxo-[1,2]thiazolo[4,5-d]pyrimidin-6-yl]acetamide |
| SMILES | O=C(Cn1cnc2c(-c3ccc(F)cc3)nsc2c1=O)Nc1ccc(Br)cc1F |
| InChI | InChI=1S/C19H11BrF2N4O2S/c20-11-3-6-14(13(22)7-11)24-15(27)8-26-9-23-17-16(25-29-18(17)19(26)28)10-1-4-12(21)5-2-10/h1-7,9H,8H2,(H,24,27) |
| InChIKey | RGAUKSBIAMACJI-UHFFFAOYSA-N |
| XLogP | 4.20 |
| TPSA | 76.88 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 477.29 |
| LogP ≤ 5 | 4.20 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 50841770 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.